Question

In: Statistics and Probability

Suppose 1% of the population of Toronto has been infected with SARS-CoV-2 at some point (call...

Suppose 1% of the population of Toronto has been infected with SARS-CoV-2 at some point (call the corresponding proportion, 0.01, the prevalence of the virus). There are now antibody tests available for SARS-CoV-2 to detect whether someone has ever been infected. However, like any test, these tests are not perfect and are subject to error at some rate.

Also suppose that, when someone has been infected, the test correctly comes up positive 98% of the time, comes up negative 1.7% of the time, and comes up inconclusive in the remaining 0.3% of cases. Also suppose that when someone has not been infected, the test correctly comes up negative 99% of the time, positive 0.8% of the time, and inconclusive 0.2% of the time.

Let ?D be the event that a randomly selected person in Toronto has truly been infected (?D for disease). Thus, ??Dc is the event that the person has never been infected. Let ++ be the event that a test comes up positive, and – the event it comes up negative. Use ?O for inconclusive.

Draw a probability tree to depict the relationship between these events (see Lecture 7). Use the tree to compute ?(?|+)P(D|+), the probability that someone has been infected conditional on getting a positive test result. What does this result mean in words and why might it be surprising (1-2 sentences)?

Use the same information about testing for SARS-CoV-2 as above. What happens if prevalence changes to 0.10? Redraw the tree, and compute ?(?|+) again using this new prevalence. What do these results suggest about the importance of prevalence in interpreting test results like this (1 sentence)? Suppose a random person in Toronto gets an inconclusive result on an antibody test for SARS-CoV-2. Is the probability that they are infected lower or higher than it was before we knew their test result? Use your tree to explain.

Solutions

Expert Solution


Related Solutions

Suppose 1% of the population of Toronto has been infected with SARS-CoV-2 at some point (call...
Suppose 1% of the population of Toronto has been infected with SARS-CoV-2 at some point (call the corresponding proportion, 0.01, the prevalence of the virus). There are now antibody tests available for SARS-CoV-2 to detect whether someone has ever been infected. However, like any test, these tests are not perfect and are subject to error at some rate. Also suppose that, when someone has been infected, the test correctly comes up positive 98% of the time, comes up negative 1.7%...
Could ELISA be used to determine if someone has been previously infected with SARS-CoV-2( the virus...
Could ELISA be used to determine if someone has been previously infected with SARS-CoV-2( the virus that causes COVID-19 diseas)? Explain.
People infected with SARS- CoV-2 (the coronavirus that causes COVID-19) can show an array of different...
People infected with SARS- CoV-2 (the coronavirus that causes COVID-19) can show an array of different symptoms and complications, ranging from mild to severe. Researchers are working to develop both prevention and treatment, including vaccines and antibody injections. Vaccines introduce antigens from viruses, without introducing the infectious virus itself. How/why do vaccines act as prevention rather than treatment? Be sure to talk about the types of cells and immune responses that vaccines are targeting, and why targeting these cells and...
Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2...
Other coronaviruses such as SARS-CoV and MERS-CoV are known suppressors of Type I IFNs. Presumably, SARS-CoV-2 employs similar strategies. Explain how SARS-CoV and MERS-CoV may interfere with Type I IFN production and signaling through their receptors.
Explain how SARS-COV-2 replicate?
Explain how SARS-COV-2 replicate?
With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2...
With all that you know about SARS-CoV-2 and Covid-19, discuss a possible evolutionary scenario for SARS-CoV-2 , over the next 6 months, 1 year and 5 years. How, if at all, will the virulence/trasmissability of SARS-CoV-2 change and why? A vaccine was developed for Polio, but, so far, not for HIV. Will science develop an effective vaccine against SARS-CoV-2? Why or why not?
A person gets infected after breathing in air-borne droplets containing SARS-CoV-2. Outline step-by-step the immune defense...
A person gets infected after breathing in air-borne droplets containing SARS-CoV-2. Outline step-by-step the immune defense at different anatomical levels of the lymphatic system from first encounter to the time when the patient develops serum anti-viral antibodies.
Describe some ways that the SARS-CoV-2 (Covid-19) pandemic will affect the following aspects of trade between...
Describe some ways that the SARS-CoV-2 (Covid-19) pandemic will affect the following aspects of trade between the US and China over the next 5 years. (a) The volume of trade? (b) The pattern of trade, i.e., what each country exports to the other? (c) The US trade deficit with China?
Discuss how our body responds to SARS-Cov-2 infection
Discuss how our body responds to SARS-Cov-2 infection
1) The spike protein on the surface of SARS-CoV-2 virus particles interacts with the ACE2 protein...
1) The spike protein on the surface of SARS-CoV-2 virus particles interacts with the ACE2 protein on our cells to initiate infection. The protein, TMPRSS2, then cleaves the spike protein allowing the virus to enter the cell. This leads to both cell death via pyroptosis and a widespread inflammatory response that damages the lung infrastructure. Scientists have identified a mutation in the TMPRSS2 gene that reduces viral entry in mice. Infected cells with the tmprss2 mutation make TMPRSS2 protein that...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT